Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Balchem Corp. (BCPC)
NASDAQ:BCPC
Earnings Data
Report Date
Apr 25, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
1.06Last Year’s EPS
1.03Same Quarter Last Year
Moderate Buy
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 21, 2025
|% Change Since: 1.48%
|Next Earnings Date:Apr 25, 2025
Earnings Call Sentiment|Positive
The earnings call highlights Balchem's strong financial results for the year and the fourth quarter, with record sales and earnings, significant growth in key segments, and a continued commitment to dividend growth. However, there were challenges in specific markets and increased operating expenses that slightly dampened the overall positive sentiment.Company Guidance
In the earnings call for Balchem's fourth quarter and full year 2024, the company reported record financial results across various metrics, showcasing strong performance in all segments. Consolidated sales for the quarter reached $240 million, a 4.9% increase year-over-year, with adjusted EBITDA hitting a record $63 million, reflecting a 13.4% increase and an adjusted EBITDA margin of 26.2%, up 200 basis points from the prior year. For the full year, Balchem achieved record sales of $954 million, a 3.4% growth, and record adjusted EBITDA of $250 million, up 8.4%. Earnings from operations for the year rose by 14.9% to $183 million. The company also generated $147 million in free cash flow, enabling a reduction in net debt to $140 million, achieving a leverage ratio of 0.6 times. The Human Nutrition & Health segment delivered strong quarterly sales growth of 6.8%, while the Animal Nutrition & Health segment showed a modest 0.3% sales growth. Specialty Products saw a 6% increase in sales due to higher performance in the Performance Gases business. Balchem also reported a 10% increase in its annual dividend, marking the 16th consecutive year of double-digit dividend growth. Looking ahead, the company anticipates continued growth in 2025 while advancing its strategic initiatives and maintaining a focus on sustainability goals.Record Full Year Sales and Earnings
Balchem achieved record full year sales of $954 million, growing 3.4% compared to the prior year, with record earnings from operations of $183 million, an increase of 14.9%, and record adjusted EBITDA of $250 million, an increase of 8.4% from the prior year.
Strong Fourth Quarter Performance
Fourth quarter consolidated revenues were $240 million, 4.9% higher than the prior year. GAAP earnings from operations for the fourth quarter increased by 23.8% versus the prior year, and adjusted EBITDA rose to $63 million, an increase of 13.4%.
Human Nutrition & Health Segment Growth
The Human Nutrition & Health segment generated sales of $147 million, an increase of 6.8% from the prior year, with earnings from operations increasing by 33.9%.
Improvement in Animal Nutrition & Health Segment
The Animal Nutrition & Health segment generated quarterly sales of $58 million, an increase of 0.3% compared to the prior year, recovering from challenging market conditions earlier in the year.
Dividend Increase
Balchem announced another increase to its annual dividend, taking it from $0.79 to $0.87 per share, a 10% increase year-over-year, marking the 16th consecutive year of double-digit growth.
---
BCPC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
BCPC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 21, 2025 | $161.34 | $163.73 | +1.48% |
| Oct 25, 2024 | $165.30 | $170.57 | +3.19% |
| Jul 26, 2024 | $173.90 | $179.84 | +3.42% |
| May 03, 2024 | $145.52 | $149.62 | +2.82% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Balchem Corp. (BCPC) report earnings?
Balchem Corp. (BCPC) is schdueled to report earning on Apr 25, 2025, TBA Not Confirmed.
What is Balchem Corp. (BCPC) earnings time?
Balchem Corp. (BCPC) earnings time is at Apr 25, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BCPC EPS forecast?
BCPC EPS forecast for the fiscal quarter 2025 (Q1) is 1.06.
---